XRAY (Dentsply Sirona) Risk Assessment


XRAY Dentsply Sirona Inc XRAY
51 GF Score
Price $12.26
GF Value $19.02
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Dentsply Sirona Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Dentsply Sirona is: High Risk: High uncertainty.

Dentsply Sirona  (NAS:XRAY) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Dentsply Sirona Risk Assessment Related Terms

XRAY vs LMAT, PLSE, KMTS: Risk Assessment Comparison

For the Medical Instruments & Supplies subindustry, Dentsply Sirona's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dentsply Sirona Risk Assessment vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Dentsply Sirona's Risk Assessment falls into.


XRAY
51GF Score
Dentsply Sirona Inc XRAY
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dentsply Sirona (XRAY) Overvalued in 2026?

Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued. The current stock price of $12.26 is trading 35.6% below its estimated GF Value™ of $19.02. GuruFocus considers Dentsply Sirona to be Possible Value Trap.

Key valuation signals for XRAY:

  • Risk Assessment:
  • GF Value™: $19.02 vs. price of $12.26 (35.6% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dentsply Sirona Business Description

Address 13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
51GF Score

Get the complete analysis for XRAY

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.26
Price
$19.02
GF Value